(It's about time huh?)
FDA Approves Pegasys(R) (Peginterferon alfa-2a) Pre-filled Syringes for the Treatment of Hepatitis C
Thursday January 8, 12:14 pm ET
- Roche continues effort to enhance hepatitis C treatment options -
NUTLEY, N.J., Jan. 8 /PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration (FDA) has approved pre-filled syringes of Pegasys� (Peginterferon alfa-2a) for the treatment of chronic hepatitis C.
[Non-text portions of this message have been removed]